{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:18:15Z","timestamp":1785431895827,"version":"3.56.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with persistent atrial fibrillation (PsAF) exhibit a high recurrence rate following catheter ablation, and there is a lack of individualized prediction tools based on clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a regularized logistic regression model for predicting long-term recurrence risk (&amp;gt;3 months post-procedure) in PsAF patients following catheter ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study enrolled 300 consecutive PsAF patients undergoing their first radiofrequency catheter ablation (RFCA) from January 2023 to December 2024 in our cardiology department. The first 250 patients were assigned to the training set for model development and internal validation, while the remaining 50 patients served as an independent external validation cohort. Demographic, echocardiographic, laboratory, and procedural parameters were collected. Feature selection was performed using LASSO regression, followed by the construction of a multivariate logistic regression prediction model and a corresponding nomogram. Model performance was evaluated using ROC curves, C-index, and calibration curves. Internal validation was conducted via bootstrap resampling, and external validation was performed on the 50-patient cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LASSO regression identified the following predictors: sex, AF duration, preoperative serum calcium, D-dimer, LDL-c, TSH, additional ablation sites, termination mode, early recurrence of atrial fibrillation (ERAF), and creatinine difference. Multivariate analysis revealed pharmacologic termination (OR\u2009=\u20090.248,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014), ERAF (OR\u2009=\u200921.188,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), and creatinine difference (OR\u2009=\u20090.976,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) as independent predictors. The model demonstrated superior discriminative ability (AUC\u2009=\u20090.808) compared to MB-LATER (0.663), APPLE (0.506), and CHA\u2082DS\u2082-VASc (0.494). Internal validation yielded a C-index of 0.803 with good calibration, while external validation maintained high performance (AUC\u2009=\u20090.882).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The regularized logistic regression model incorporating clinical parameters accurately predicts long-term recurrence risk post-ablation in PsAF patients, outperforming traditional risk scoring systems and showing significant potential for clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1713560","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:33:39Z","timestamp":1765521219000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and validation of a regularized logistic regression model for predicting late recurrence after ablation in persistent atrial fibrillation: a clinical parameter approach"],"prefix":"10.3389","volume":"12","author":[{"given":"Weijia","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.23736\/S2724-5683.23.06299-3","article-title":"Ten-year trends in incidence and prevalence of atrial fibrillation and flutter in Denmark according to demographics, ethnicity, educational level, and area of residence (2009\u20132018)","volume":"71","author":"Brodersen","year":"2023","journal-title":"Minerva Cardiol Angiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e002140","DOI":"10.1136\/openhrt-2022-002140","article-title":"Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland","volume":"9","author":"Lehto","year":"2022","journal-title":"Open Heart"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population","volume":"202","author":"Kim","year":"2018","journal-title":"Am Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"zwae175.339","DOI":"10.1093\/eurjpc\/zwae175.339","article-title":"Trends in burden of atrial fibrillation overthree decades: a population-based study","volume":"31","author":"Yang","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e005155","DOI":"10.1161\/JAHA.116.005155","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","volume":"6","author":"Lane","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.5114\/aoms.2018.77546","article-title":"Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range","volume":"15","author":"Wa\u0144kowicz","year":"2019","journal-title":"Arch Med Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"ehac544.2240","DOI":"10.1093\/eurheartj\/ehac544.2240","article-title":"Risk factors and prognosis for heart failure in atrial fibrillation subtypes in women and men","volume":"43","author":"Espnes","year":"2022","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/jcm10143129","article-title":"Persistent atrial fibrillation: the role of left atrial posterior wall isolation and ablation strategies","volume":"10","author":"Kaba","year":"2021","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/bjca.2020.0170","article-title":"Modifiable risk factors, symptoms, wellbeing and treatment expectations in patients with atrial fibrillation","volume":"16","author":"Lachonius","year":"2021","journal-title":"Br J Card Nurs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e11520","DOI":"10.1097\/MD.0000000000011520","article-title":"Long-term outcome of radiofrequency catheter ablation for persistent atrial fibrillation","volume":"97","author":"Yubing","year":"2018","journal-title":"Medicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1111\/anec.70024","article-title":"Evaluating the prognostic significance of cystatin C level variations pre- and post-radiofrequency catheter ablation in the recurrence of persistent atrial fibrillation","volume":"29","author":"Zhang","year":"2024","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10557-022-07353-9","article-title":"Development and validation of a novel prognostic model predicting the atrial fibrillation recurrence risk for persistent atrial fibrillation patients treated with nifekalant during the first radiofrequency catheter ablation","volume":"37","author":"Dong","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/bjs.10895","article-title":"LASSO regression","volume":"105","author":"Ranstam","year":"2018","journal-title":"Br J Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.70882\/josrar.2025.v2i1.35","article-title":"Linear regression approach to solving multicollinearity and overfitting in predictive analysis","volume":"2","author":"Otse","year":"2025","journal-title":"J Sci Res Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41598-024-84342-y","article-title":"Application of the LASSO regularisation technique in mitigating overfitting in air quality prediction models","volume":"15","author":"Pak","year":"2025","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/sim.6782","article-title":"Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events","volume":"35","author":"Pavlou","year":"2015","journal-title":"Stat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00392-015-0856-x","article-title":"The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation","volume":"104","author":"Kornej","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/EUROPACE\/EUZ233","article-title":"Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: the Leipzig heart center AF ablation registry","volume":"21","author":"Kornej","year":"2019","journal-title":"EP Europace"},{"key":"B20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.hjc.2023.12.003","article-title":"Including hemoglobin levels and female sex provide the additional predictive value of the APPLE score for atrial fibrillation recurrence post-catheter ablation","volume":"82","author":"Huang","year":"2023","journal-title":"Hellenic J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jacep.2020.09.029","article-title":"Early recurrence is reliable predictor of late recurrence after radiofrequency catheter ablation of atrial fibrillation","volume":"7","author":"Kim","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"864417","DOI":"10.3389\/fcvm.2022.864417","article-title":"Long atrial fibrillation duration and early recurrence are reliable predictors of late recurrence after radiofrequency catheter ablation","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4020\/JHRS.27.BPC_6","article-title":"Predictors for late recurrence of atrial fibrillation after radiofrequency catheter ablation: over 500 cases experience","volume":"27","author":"Shim","year":"2011","journal-title":"J Arrhythm"},{"key":"B24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12872-022-02816-1","article-title":"Early recurrence after cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: mechanism and implication in long-term outcome","volume":"22","author":"Wei","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.hrthm.2024.01.020","article-title":"Early atrial fibrillation recurrence post catheter ablation: analysis from insertable cardiac monitor in the era of optimized radiofrequency ablation","volume":"21","author":"De Becker","year":"2024","journal-title":"Heart Rhythm"},{"key":"B26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1253\/circj.CJ-15-1051","article-title":"Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies\u2014prospective comparison of radiofrequency vs. second-generation cryoballoon ablation","volume":"80","author":"Miyazaki","year":"2016","journal-title":"Circ J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jacep.2021.01.011","article-title":"The blinding period following ablation therapy for atrial fibrillation: proarrhythmic and antiarrhythmic pathophysiological mechanisms","volume":"7","author":"Gottlieb","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/jcm14092919","article-title":"Beyond pulmonary vein reconnection: exploring the dynamic pathophysiology of atrial fibrillation recurrence after catheter ablation","volume":"14","author":"Vlachakis","year":"2025","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1540-8167.2012.02416.x","article-title":"Early recurrences are not always benign after catheter ablation of atrial fibrillation:do we need to reassess the need for a blanking period?","volume":"23","author":"Kumar","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1389450121666200302095103","article-title":"The efficacy of anti-inflammatory agents in the prevention of atrial fibrillation recurrences","volume":"28","author":"Nomani","year":"2020","journal-title":"Curr Med Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/clc.23663","article-title":"Effect of electrical cardioversion on 1-year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation","volume":"44","author":"Dong","year":"2021","journal-title":"Clin Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5830\/CVJA-2020-060","article-title":"Efficacy of amiodarone for the prevention of atrial fibrillation recurrence after cardioversion","volume":"32","author":"Istratoaie","year":"2021","journal-title":"Cardiovasc J Afr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/europace\/euac143","article-title":"Predictors of recurrence after catheter ablation and electrical cardioversion of atrial fibrillation: an umbrella review of meta-analyses","volume":"25","author":"Charitakis","year":"2022","journal-title":"Europace"},{"key":"B34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/jcdd10040151","article-title":"Long-term renal function after catheter ablation of atrial fibrillation","volume":"10","author":"Kova\u010devi\u0107","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.2147\/JIR.S496590","article-title":"Inflammation and nutritional status mediated the increased of risk of atrial fibrillation recurrence associated with eGFRdiff post-ablation","volume":"17","author":"Huang","year":"2024","journal-title":"J Inflamm Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jjcc.2020.07.002","article-title":"Improvement in renal and endothelial function after catheter ablation in patients with persistentatrial fibrillation","volume":"76","author":"Okawa","year":"2020","journal-title":"J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.mayocp.2020.11.005","article-title":"Atrial fibrillation and endothelial dysfunction: a potential link?","volume":"96","author":"Corban","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1253\/circj.CJ-20-0149","article-title":"Impact of renal dysfunction on left atrial structural remodeling and recurrence after catheter ablation for atrial fibrillation\u2014A propensity score matching analysis","volume":"84","author":"Takahashi","year":"2020","journal-title":"Circ J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fcvm.2019.00082","article-title":"Does chronic kidney disease result in high risk of atrial fibrillation?","volume":"6","author":"Zhang","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCRESAHA.120.317872","article-title":"Machine learning in arrhythmia and electrophysiology","volume":"128","author":"Trayanova","year":"2021","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e007952","DOI":"10.1161\/CIRCEP.119.007952","article-title":"Artificial intelligence and machine learning in arrhythmias and cardiac electrophysiology","volume":"13","author":"Feeny","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/jpm15050205","article-title":"A talk with ChatGPT: the role of artificial intelligence in shaping the future of cardiology and electrophysiology","volume":"15","author":"Cersosimo","year":"2025","journal-title":"J Pers Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1713560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:33:40Z","timestamp":1765521220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1713560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":42,"alternative-id":["10.3389\/fcvm.2025.1713560"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1713560","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"article-number":"1713560"}}